X4 PHARMACEUTICALS, INC (XFOR) Gross profit 2022–2025
X4 PHARMACEUTICALS, INC (XFOR) annual gross profit history from SEC filings — each fiscal year as reported.
$29.4MFY2025 · since FY2022: $0 → $29.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $29.4M | +1568.0% |
| FY2024 | $1.8M | — |
| FY2023 | $0 | — |
| FY2022 | $0 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More XFOR financial trends
XFOR RevenueXFOR Net incomeXFOR Net marginXFOR Gross marginXFOR Operating incomeXFOR Operating marginXFOR Operating cash flowXFOR Free cash flowXFOR Capital expendituresXFOR Return on equityXFOR Stock buybacksXFOR Dividends paidXFOR Total assetsXFOR Total liabilitiesXFOR Shareholders’ equityXFOR overview →